Hemo Organic informs about quarterly statement of investor complaints

22 Jul 2017 Evaluate

Hemo Organic has submitted the Statement of Investor Complaints for the quarter June, 2017. The Company has not received any complaint during the quarter and there was no complaint outstanding for the resolution.

The above information is a part of company’s filings submitted to BSE.

Hemo Organic Share Price

11.00 0.08 (0.73%)
14-May-2024 10:11 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.90
Dr. Reddys Lab 5880.90
Cipla 1382.75
Zydus Lifesciences 995.05
Lupin 1640.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.